Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting cardiovascular disease in familial hypercholesterolemia.

Current opinion in lipidology - 1 Aug 2018

Paquette Martine, Baass Alexis

Abstract excerpt

PURPOSE OF REVIEW: Familial hypercholesterolemia is a frequent genetic disease associated with a high lifetime risk of cardiovascular disease (CVD). Statins are the cornerstone of treatment of familial hypercholesterolemia; however, with the advent of novel LDL-cholesterol lowering therapies, it has become necessary to identify familial hypercholesterolemia subjects presenting a significant residual CVD risk. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Genetic Predisposition to Disease
Share to Hyperlipoproteinemia Type II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Risk Assessment

Source

Identifiers

PMID: 29708923
DOI: 10.1097/MOL.0000000000000519

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting cardiovascular disease in familial hypercholesterolemia.PMID 29708923Read ↗

Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels.Semantic proximity Read ↗

The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia.Semantic proximity Read ↗

Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial HypercholesterolemiaSemantic proximity Read ↗

Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.Semantic proximity Read ↗

Early atherosclerosis in familial hypercholesterolemia patients: significance of vascular markers for risk stratificationSemantic proximity Read ↗

Cardiovascular risk stratification in familial hypercholesterolaemia.Semantic proximity Read ↗

Familial hypercholesterolemia: experience from the French-Canadian population.Semantic proximity Read ↗

Genetic Influence on LDL-Cholesterol Levels: Role of Polygenic Risk Scores and Lp(a) Beyond Monogenic Hypercholesterolemia.Semantic proximity Read ↗

Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update.Semantic proximity Read ↗

A Promising Biomarker for Predicting Cardiovascular Risk in Asymptomatic Familial Hypercholesterolemia Patients From The SAFEHEART StudySemantic proximity Read ↗

The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectivesSemantic proximity Read ↗

Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.